Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
The biopharma world's manufacturing weekly
Manufacturing channel feed
AstraZeneca budgets another $2B to boost manufacturing and R&D in US
8 months ago
R&D
Thermo Fisher consolidates viral vector work in Massachusetts, cuts 160 workers
8 months ago
People
FDA records request lands Chinese API manufacturer on blocked import list
8 months ago
Pharma
FDA+
Coherus restarts biosimilar supply after delays; Novavax ends Covid vaccine deal with UK
8 months ago
Avid Bioservices to be sold to private equity firms for $1.1B
8 months ago
Deals
Catalent touts customer confidence ahead of Novo deal, but misses revenue estimates
8 months ago
Nektar divests manufacturing site and reagent arm for $90M
8 months ago
Deals
Viking CEO on ‘shocking’ market reaction to oral obesity data, preparing for Phase 3
8 months ago
R&D
European Commission marks Dec. 6 for Novo-Catalent deal decision
8 months ago
Deals
Baxter pulls IV products out of China to shift supply to the US
8 months ago
China
WuXi in ‘early stages’ of CGT business review; Lonza exec becomes AGC Bio CEO
8 months ago
Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA
8 months ago
FDA+
MilliporeSigma invests €70M to triple ADC manufacturing at US site
8 months ago
WuXi AppTec is still signing on new clients despite Biosecure threat
8 months ago
China
Telix's new radiopharma spinout banks on one trial for success, CEO says
8 months ago
Startups
Post-Hoc: Novo’s obesity enemies
8 months ago
Editor's note
Pharma
GSK to spend $800M to build two vaccine factories in the US
8 months ago
Lonza extends contract with unnamed pharma; Rentschler's new build
8 months ago
Allowing Novo-Catalent deal to close would be ‘wrong decision’ by antitrust authorities, Roche CEO says
8 months ago
Pharma
Thermo Fisher predicts revenue uptick in 2025 as it expects headwinds to ease
8 months ago
Pharma
Samsung Bio inks largest deal yet worth $1.24B with unnamed Asian pharma
8 months ago
Deals
FDA hits Camurus with CRL for acromegaly therapy over manufacturing issues
8 months ago
FDA+
AstraZeneca-backed CDMO Nucleus RadioPharma to boost commercial capacity
8 months ago
Pharma
Catalent moves to reassure customers about what happens after merger
8 months ago
Pharma
First page
Previous page
6
7
8
9
10
11
12
Next page
Last page
